Company news
Stay ahead with Sphere Bio
Join our community of forward-thinking scientists and stay informed with the latest breakthroughs, product launches, and exclusive offers. By subscribing to our newsletter, you'll be the first to know about innovations that can transform your lab.

Fluidic Sciences Acquires Business and Assets of Sphere Bio to Accelerate Single-Cell and Protein Interaction Discovery
Sphere Bio awarded Best Droplet Microfluidic Technology Company 2025
APAC distribution network expanded to strengthen presence in region
Cyto-Cellect® Human IgG Kappa and Viability Assay Kit launched for efficient single-cell selection
Sphere Bio joins MabDesign to strengthen connections in European biotherapeutics
Sphere Fluidics rebrands to Sphere Bio
Sphere Bio launches Cyto-Mine® Chroma and announces Early Access Program
Cyto-Cellect® Fc Fusion Assay Kit launched to expedite cell line development for fusion proteins
Sphere Bio strengthens global commercial teams and establishes direct sales and support channel in North America

Cyto-Mine® Chroma announced to accelerate and streamline workflows
Dr. Alex Dickinson appointed as Non-Executive Director
Sphere Bio awarded gold accreditation by Investors in People
Sphere Bio Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024

Cyto-Cellect® PLUS launched to accelerate cell line development workflows

Curtis Nicholson appointed as Director of Sales, EMEA, to support accelerated growth in key markets

Dale Levitzke appointed as Chief Executive Officer

Edward Rayner appointed as Non-Executive Director

Dr. Graeme Daniels appointed as Vice President of Sales and Marketing

Cyto-Mine® selected by FairJourney Biologics to advance cell line development workflows
Cyto-Mine® capabilities expanded to meet cGMP requirements for drug manufacture workflows

Biosyntia chooses Pico-Mine® platform to accelerate synthetic biology and metabolic workflows

Brand identity update aligns ambitious, global commercial growth strategy

Kenneth Hitchner appointed as Chairman
3DSecret program begins to investigate mechanisms of metastasis in cancer

Richard Hammond appointed as Chief Technical Officer
New laboratory facilities opened at Granta Park in Cambridge, UK supports growth

Commercial team strengthened with three new senior hires
View upcoming events we will be attending
Don't miss out on the chance to meet us in person at one of the many events we will be attending this year. Check out our list of upcoming events.